The global pharmaceutical excipients market size is expected to reach around US$ 14.2 billion by 2030 and is expected to grow at an impressive double-digit rate of 5.39% from 2022 to 2030.
The protection & effectiveness associated with the biopharmaceutical items, along with its capability to address formerly untreatable conditions, thus allowing pharmaceutical businesses to keep high cost for innovative medicines, thus contributing notably to the overall growth of the market.
The study includes drivers and restraints of this market. The study provides an analysis of the global pharmaceutical excipients market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Report Scope of the Pharmaceutical Excipients Market
| Report Coverage | Details |
| Market Size by 2030 | USD 14.2 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.39% |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1761
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global pharmaceutical excipients market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global pharmaceutical excipients market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global pharmaceutical excipients market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical excipients are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global pharmaceutical excipients market include:
- Ashland Global Holdings
- BASF SE
- DuPont
- Roquette Feres
- Evonik Industries AG
- Associated British Foods
- Archer Daniels Midland Company
- Lubrizol Corporation
- Croda International
- Kerry Group
Market Segmentation:
By Product
- Organic Chemicals
- Inorganic Chemicals
- Others
By Functionality
- Fillers and Diluents
- Suspending and Viscosity Agents
- Coating Agents
- Binders
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Flavoring Agents and Sweeteners
- Other Functionalities
By Formulations
- Topical Formulations
- Oral Formulations
- Parenteral Formulations
- Other Formulations
By End-Users
- Pharmaceuticals Companies
- Research Organization
- Academics
- Others
By Distribution Channel
- Online Pharmacy
- Retail
- Mail-Order
Regional Analysis:
The geographical analysis of the global pharmaceutical excipients market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global pharmaceutical excipients Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global pharmaceutical excipients market in 2030?
- What is the expected CAGR for the pharmaceutical excipients market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global pharmaceutical excipients market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Excipients Market
5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Excipients Market, By Product
8.1. Pharmaceutical Excipients Market, by Product, 2022-2030
8.1.1. Organic Chemicals
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Inorganic Chemicals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmaceutical Excipients Market, By Functionality
9.1. Pharmaceutical Excipients Market, by Functionality, 2022-2030
9.1.1. Fillers and Diluents
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Suspending and Viscosity Agents
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Coating Agents
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Binders
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Disintegrants
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Colorants
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Lubricants and Glidants
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Preservatives
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Emulsifying Agents
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Flavoring Agents and Sweeteners
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Other Functionalities
9.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmaceutical Excipients Market, By Formulations
10.1. Pharmaceutical Excipients Market, by Formulations, 2022-2030
10.1.1. Topical Formulations
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Oral Formulations
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Parenteral Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmaceutical Excipients Market, By End-Users
11.1. Pharmaceutical Excipients Market, by End-Users, 2022-2030
11.1.1. Pharmaceuticals Companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Research Organization
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Academics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Pharmaceutical Excipients Market, By Distribution Channel
12.1. Pharmaceutical Excipients Market, by Distribution Channel, 2022-2030
12.1.1. Online Pharmacy
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Retail
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Mail-Order
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.7. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.10. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 14. Company Profiles
14.1. Ashland Global Holdings
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DuPont
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roquette Feres
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Evonik Industries AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Associated British Foods
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Archer Daniels Midland Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lubrizol Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Croda International
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Kerry Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments